• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FT4 II - FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FT4 II - FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 06437281160
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/15/2016
Event Type  malfunction  
Event Description
The customer stated that the thyroid panel results for two samples from the same patient tested on an e602 analyzer did not match results obtained from other vendor analyzers and did not match the diagnosis of the patient.The patient was originally seen at an initial site and was referred to the customer site due to abnormal test results without clinical symptoms.The results for the two samples from the customer site were said to match the results from the initial site.No results were provided from the initial site.The two samples had erroneous free thyroxine (ft4) and thyrotropin (tsh) results that are reportable as a malfunction.The erroneous results were not reported outside of the laboratory.This medwatch will refer to ft4.Please refer to the medwatch with patient identifier (b)(6) for information related to tsh.Please refer to the attachment for the results from the two samples.The samples were initially tested at the customer site on an e602 analyzer and correspond to the "roche" results on the attachment.The first sample was repeated on a beckman dxi analyzer (corresponding to "dxi" results on the attachment) and a siemens centaur analyzer (corresponding to "centaur" results on the attachment).The results from the centaur analyzer were believed to be correct since they match the patient diagnosis.The first sample was also treated with streptavidin agarose and a heterophile blocking tube (hbt) from scantabodies, then tested on the e602 analyzer.The agarose and hbt treated sample results correspond to the "roche agarose" and "roche hbt" results respectively in the attachment.The patient was not adversely affected.The e602 analyzer serial number was (b)(4).The customer declined a service visit and stated that he believes the issue to be sample related.
 
Manufacturer Narrative
The samples were provided for investigation.Investigations were not able to confirm the ft4 values generated at the customer site.It was determined that the sample contained a slight interference to the streptavidin used in the ft4 reagent.This limitation is covered in product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FT4 II - FREE THYROXINE
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5784808
MDR Text Key49239383
Report Number1823260-2016-00891
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Medical Technologist
Type of Report Initial,Followup
Report Date 08/30/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2016
Device Catalogue Number06437281160
Device Lot Number18861000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/16/2016
Initial Date FDA Received07/12/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/30/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age30 YR
-
-